Autobahn Therapeutics

Developer of regenerative medicines and brain-targeting therapeutics intended for restoring the hopes of people affected by central nervous system disorders. The company's medicines are focused on hig...

Healthcare

San Diego, CA, United States

Founded 2017

32 employees

Website

Valuation

$218M

Market implied

Share Price

N/A

Total Raised

$214.5M

Last Round

N/A

Investors

+18 other investors

View all 18 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Autobahn Therapeutics's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required